Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.37 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | FOLH1 | Q04609 | 12/20 | 0.34 |
| ▸ | ALB | P02768 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | OTC | P00480 | 1/20 | 0.33 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.33 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.33 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29299668 | 0.96 | NOD1 (0.37) | NOD1DPP7TP53SMN1; SMN2FOLH1 | |
| SCHEMBL29300537 | 0.89 | NOD1 (0.36) | NOD1DPP7TP53SMN1; SMN2FOLH1 | |
| SCHEMBL27331646 | 0.88 | ALDH1A1 (0.39) | TP53SMN1; SMN2FOLH1ALBSIGMAR1 | |
| SCHEMBL29299665 | 0.87 | DPP7 (0.43) | NOD1DPP7TP53SMN1; SMN2FOLH1 | |
| SCHEMBL29299824 | 0.86 | DPP7 (0.43) | NOD1DPP7TP53SMN1; SMN2FOLH1 | |
| SCHEMBL29299811 | 0.85 | DPP7 (0.45) | NOD1DPP7TP53SMN1; SMN2FOLH1 | |
| SCHEMBL29299797 | 0.84 | DPP7 (0.46) | NOD1DPP7TP53SMN1; SMN2FOLH1 | |
| SCHEMBL29300536 | 0.81 | DPP7 (0.50) | NOD1DPP7TP53SMN1; SMN2FOLH1 | |
| SCHEMBL29299823 | 0.79 | SMN1; SMN2 (0.37) | DPP7TP53SMN1; SMN2FOLH1SIGMAR1 | |
| SCHEMBL29299829 | 0.78 | SMN1; SMN2 (0.46) | TP53SMN1; SMN2FOLH1ALBSIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024129600-A1 | GONADOTROPIN-RELEASING HORMONE RECEPTOR (GNRHR) TARGETED THERAPEUTICS AND USES THEREOF | RADIONETICS ONCOLOGY, INC. (US) | 2024-06-20 | — | — | WO | disclosed |